These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 21071432)

  • 41. Vascular type of Ehlers-Danlos syndrome.
    Watanabe A; Shimada T
    J Nippon Med Sch; 2008 Oct; 75(5):254-61. PubMed ID: 19023163
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Early venous manifestation of Ehlers-Danlos syndrome Type IV through a novel mutation in COL3A1.
    Wendorff H; Pelisek J; Zimmermann A; Mayer K; Seidel H; Weirich G; Hausser I; Siegel C; Zernecke A; Eckstein HH
    Cardiovasc Pathol; 2013; 22(6):488-92. PubMed ID: 23688910
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Generation of two iPSC lines from vascular Ehlers-Danlos Syndrome (vEDS) patients carrying a missense mutation in COL3A1 gene.
    Manhas A; Tripathi D; Noishiki C; Wu D; Liu L; Sallam K; Lee JT; Fukaya E; Sayed N
    Stem Cell Res; 2024 Sep; 79():103485. PubMed ID: 38944978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience.
    Oderich GS; Panneton JM; Bower TC; Lindor NM; Cherry KJ; Noel AA; Kalra M; Sullivan T; Gloviczki P
    J Vasc Surg; 2005 Jul; 42(1):98-106. PubMed ID: 16012458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative therapeutic strategies for preventing aortic rupture in a mouse model of vascular Ehlers-Danlos syndrome.
    Legrand A; Guery C; Faugeroux J; Fontaine E; Beugnon C; Gianfermi A; Loisel-Ferreira I; Verpont MC; Adham S; Mirault T; Hadchouel J; Jeunemaitre X
    PLoS Genet; 2022 Mar; 18(3):e1010059. PubMed ID: 35245290
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Next-generation sequencing and a novel COL3A1 mutation associated with vascular Ehlers-Danlos syndrome with severe intestinal involvement: a case report.
    Cortini F; Marinelli B; Seia M; De Giorgio B; Pesatori AC; Montano N; Bassotti A
    J Med Case Rep; 2016 Oct; 10(1):303. PubMed ID: 27799058
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ehlers-Danlos syndrome type IV: unusual congenital anomalies in a mother and son with a COL3A1 mutation and a normal collagen III protein profile.
    Kroes HY; Pals G; van Essen AJ
    Clin Genet; 2003 Mar; 63(3):224-7. PubMed ID: 12694234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vascular Ehlers-Danlos syndrome.
    Germain DP; Herrera-Guzman Y
    Ann Genet; 2004; 47(1):1-9. PubMed ID: 15127738
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A novel mutation in COL3A1 associates to vascular Ehlers-Danlos syndrome with predominant musculoskeletal involvement.
    Ruscitti F; Trevisan L; Rosti G; Gotta F; Cianflone A; Geroldi A; Origone P; Pichiecchio A; Viglio S; Iascone M; Mandich P
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1753. PubMed ID: 34318601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A base substitution at a splice site in the COL3A1 gene causes exon skipping and generates abnormal type III procollagen in a patient with Ehlers-Danlos syndrome type IV.
    Cole WG; Chiodo AA; Lamande SR; Janeczko R; Ramirez F; Dahl HH; Chan D; Bateman JF
    J Biol Chem; 1990 Oct; 265(28):17070-7. PubMed ID: 2145268
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical, structural, biochemical and X-ray crystallographic correlates of pathogenicity for variants in the C-propeptide region of the COL3A1 gene.
    Stembridge NS; Vandersteen AM; Ghali N; Sawle P; Nesbitt M; Pollitt RC; Ferguson DJ; Holden S; Elmslie F; Henderson A; Hulmes DJ; Pope FM
    Am J Med Genet A; 2015 Aug; 167A(8):1763-72. PubMed ID: 25846194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Three arginine to cysteine substitutions in the pro-alpha (I)-collagen chain cause Ehlers-Danlos syndrome with a propensity to arterial rupture in early adulthood.
    Malfait F; Symoens S; De Backer J; Hermanns-Lê T; Sakalihasan N; Lapière CM; Coucke P; De Paepe A
    Hum Mutat; 2007 Apr; 28(4):387-95. PubMed ID: 17211858
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A New COL3A1 Mutation in Ehlers-Danlos Syndrome Vascular Type With Different Phenotypes in the Same Family.
    Cortini F; Marinelli B; Romi S; Seresini A; Pesatori AC; Seia M; Montano N; Bassotti A
    Vasc Endovascular Surg; 2017 Apr; 51(3):141-145. PubMed ID: 28183226
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Vascular Ehlers-Danlos Syndrome: A Comprehensive Natural History Study in a Dutch National Cohort of 142 Patients.
    Demirdas S; van den Bersselaar LM; Lechner R; Bos J; Alsters SIM; Baars MJH; Baas AF; Baysal Ö; van der Crabben SN; Dulfer E; Giesbertz NAA; Helderman-van den Enden ATJM; Hilhorst-Hofstee Y; Kempers MJE; Komdeur FL; Loeys B; Majoor-Krakauer D; Ockeloen CW; Overwater E; van Tintelen PJ; Voorendt M; de Waard V; Maugeri A; Brüggenwirth HT; van de Laar IMBH; Houweling AC
    Circ Genom Precis Med; 2024 Jun; 17(3):e003978. PubMed ID: 38623759
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ehlers-Danlos syndrome type IV: phenotypic consequences of a splicing mutation in one COL3A1 allele.
    Sillence DO; Chiodo AA; Campbell PE; Cole WG
    J Med Genet; 1991 Dec; 28(12):840-5. PubMed ID: 1757960
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vascular Ehlers-Danlos syndrome: a case with fatal outcome.
    Morais P; Mota A; Eloy C; Lopes JM; Torres F; Palmeiro A; Tavares P; Azevedo F
    Dermatol Online J; 2011 Apr; 17(4):1. PubMed ID: 21549076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Frameshift COL3A1 Variant in Vascular Ehlers-Danlos Syndrome.
    Olson SL; Murray ML; Skeik N
    Ann Vasc Surg; 2019 Nov; 61():472.e9-472.e13. PubMed ID: 31394236
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nonsyndromic arteriopathy and aortopathy and vascular Ehlers-Danlos syndrome causing COL3A1 variants.
    Yagi H; Takeda N; Amiya E; Akiyama N; Chang H; Ishiura H; Sato J; Akazawa H; Morita H; Komuro I
    Am J Med Genet A; 2022 Sep; 188(9):2777-2782. PubMed ID: 35543214
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Phenotype of COL3A1/COL5A2 deletion patients.
    Kempers MJ; Wessels M; Van Berendoncks A; van de Laar IM; de Leeuw N; Loeys B
    Eur J Med Genet; 2022 Oct; 65(10):104593. PubMed ID: 35964930
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sudden death as a result of colon perforation; Ehlers-Danlos type IV case with postmortem diagnosis.
    Güven S; Kule O; Güleş D; Okumuş H; Oruç M; Celbiş O
    J Forensic Leg Med; 2020 Jul; 73():101969. PubMed ID: 32442117
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.